Cargando…

P16 COVID-19 Vaccination Strategies Considering a Vaccine Adapted to a New Variant of Concern: A Decision-Analytic Modeling Study

Detalles Bibliográficos
Autores principales:	Jahn, B., Sroczynski, G., Bicher, M., Rippinger, C., Mühlberger, N., Santamaria, J., Urach, C., Popper, N., Siebert, U.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9232700/ http://dx.doi.org/10.1016/j.jval.2022.04.022

Ejemplares similares

POSA172 How to Optimize COVID-19 Vaccination Considering Limited Vaccination Capacities: A Decision-Analytic Framework and Modeling Study
por: Jahn, B, et al.
Publicado: (2022)

HPR171 COVID 19 Vaccination - How to Support Decisions on Vaccination Prioritization for New Variants of Concern?
por: Jahn, B, et al.
Publicado: (2022)

An iterative algorithm for optimizing COVID-19 vaccination strategies considering unknown supply
por: Bicher, Martin, et al.
Publicado: (2022)

Evaluation of undetected cases during the COVID-19 epidemic in Austria
por: Rippinger, C., et al.
Publicado: (2021)

Targeted COVID-19 Vaccination (TAV-COVID) Considering Limited Vaccination Capacities—An Agent-Based Modeling Evaluation
por: Jahn, Beate, et al.
Publicado: (2021)

Time Dynamics of the Spread of Virus Mutants with Increased Infectiousness in Austria
por: Bicher, Martin, et al.
Publicado: (2022)

Model based estimation of the SARS-CoV-2 immunization level in austria and consequences for herd immunity effects
por: Bicher, Martin, et al.
Publicado: (2022)

Decision-analytic modeling for early health technology assessment of medical devices – a scoping review
por: Conrads-Frank, Annette, et al.
Publicado: (2022)

Contact Tracing for Disease Containment: a Network-Based Analysis*()
por: Gigler, Felix, et al.
Publicado: (2022)

Supporting COVID-19 policy-making with a predictive epidemiological multi-model warning system
por: Bicher, Martin, et al.
Publicado: (2022)

Decision-analytic modeling to evaluate the long-term effectiveness and cost-effectiveness of HPV-DNA testing in primary cervical cancer screening in Germany
por: Sroczynski, Gaby, et al.
Publicado: (2010)

Decision-analytic evaluation of the comparative effectiveness and cost-effectiveness of strategies to prevent breast and ovarian cancer in German women with BRCA-1/2 mutations
por: Hallsson, Lára R., et al.
Publicado: (2023)

How an election can be safely planned and conducted during a pandemic: Decision support based on a discrete event model
por: Weibrecht, Nadine, et al.
Publicado: (2021)

HCV-related burden of disease in Europe: a systematic assessment of incidence, prevalence, morbidity, and mortality
por: Mühlberger, Nikolai, et al.
Publicado: (2009)

Causal evidence in health decision making: methodological approaches of causal inference and health decision science
por: Kühne, Felicitas, et al.
Publicado: (2022)

COVID-19 vaccine decisions: considering the choices and opportunities
por: Hotez, Peter J., et al.
Publicado: (2021)

Why should we apply ABM for decision analysis for infectious diseases?—An example for dengue interventions
por: Miksch, Florian, et al.
Publicado: (2019)

Vaccine allergy: evidence to consider for COVID-19 vaccines
por: Nilsson, Lennart, et al.
Publicado: (2021)

EPH206 Strategies to Address Vaccine Hesitancy in Adults: A Systematic Review
por: Santamaria, J, et al.
Publicado: (2022)

Energy-saving and pricing decisions in a sustainable supply chain considering behavioral concerns
por: Chen, Bin, et al.
Publicado: (2020)

Statistical methods and modelling techniques for analysing hospital readmission of discharged psychiatric patients: a systematic literature review
por: Urach, Christoph, et al.
Publicado: (2016)

Assessment of effectiveness and cost-effectiveness of HPV testing in primary screening for cervical
por: Mittendorf, Thomas, et al.
Publicado: (2007)

Stool DNA testing for early detection of colorectal cancer: systematic review using the HTA Core Model(®) for Rapid Relative Effectiveness Assessment
por: Stürzlinger, Heidi, et al.
Publicado: (2023)

Cost-effectiveness of new pneumococcal conjugate vaccines in Turkey: a decision analytical model
por: Bakır, Mustafa, et al.
Publicado: (2012)

Antiviral combination therapy with interferon/peginterferon plus ribavirin for patients with chronic hepatitis C in Germany: a health technology assessment commissioned by the German Agency for Health Technology Assessment
por: Siebert, Uwe, et al.
Publicado: (2003)

Challenges of COVID-19 vaccination in Afghanistan: A rising concern
por: Essar, M.Y., et al.
Publicado: (2021)

Vergleich der Effektivität von multiplen dynamischen Behandlungsstrategien unter Nutzung der Target-Trial-Emulierung: Kontrafaktischer Ansatz zur Kausalinferenz aus Real-World-Daten
por: Kuehne, Felicitas, et al.
Publicado: (2023)

Benefits and harms of prostate cancer screening – predictions of the ONCOTYROL prostate cancer outcome and policy model
por: Mühlberger, Nikolai, et al.
Publicado: (2017)

Points to Consider in the Development and Information Provision of Vaccines for Vaccination during Pregnancy: A Survey
por: Nomura, Yumiko, et al.
Publicado: (2022)

Equitable and effective vaccine access considering vaccine hesitancy and capacity constraints
por: Sengul Orgut, Irem, et al.
Publicado: (2023)

Optimal Pricing Decisions for a Low-Carbon Supply Chain Considering Fairness Concern under Carbon Quota Policy
por: Zou, Hao, et al.
Publicado: (2021)

Some Points Concerning Vaccination
Publicado: (1882)

Balancing Evidence and Uncertainty when Considering Rubella Vaccine Introduction
por: Lessler, Justin, et al.
Publicado: (2013)

Reproduction of patterns in melanocytic proliferations by agent-based simulation and geometric modeling
por: Schneckenreither, Günter, et al.
Publicado: (2021)

COVID-19 vaccination: Is it a matter of concern?
por: Kushwaha, Poonam, et al.
Publicado: (2022)

National differences in vaccine hesitancy: a concern for the external validity of vaccine studies
por: Ammitzbøll, Christian, et al.
Publicado: (2021)

A novel mathematical model for prioritization of individuals to receive vaccine considering governmental health protocols
por: Shamsi Gamchi, N., et al.
Publicado: (2022)

The benefit of considering others in individual health decisions
por: Sievert, Elisabeth D. C.
Publicado: (2023)

Application of Decision-Analytic Models in Personalized Medicine for CML Treatment Decisions Made by Payers, Providers, and Patients
por: Saverno, Kim R., et al.
Publicado: (2012)

Pharmacogenomics Bias - Systematic distortion of study results by genetic heterogeneity
por: Siebert, Uwe, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_jr12m9m2illb2pgc3iomrr4b60